Key result
Diabetic dyslipidemia, characterized by high triglycerides and low HDL cholesterol, contributes to residual cardiovascular risk in type 2 diabetes despite statin therapy.
Population
Patients with type 2 diabetes
Design
Review
Authors
Loading...
Residual CV risk from diabetic dyslipidemia persists in T2D on statins; leaves optimal triglyceride/HDL management open for trials.
This review highlights that despite statin therapy, patients with type 2 diabetes remain at high cardiovascular risk due to atherogenic dyslipidemia, and evidence for managing high triglycerides and low HDL remains inconclusive.
Bitzur et al. (2009) conducted a review in Diabetic dyslipidemia. Management of diabetic dyslipidemia was evaluated. Diabetic dyslipidemia, characterized by high triglycerides and low HDL cholesterol, contributes to residual cardiovascular risk in type 2 diabetes despite statin therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: